Ajo LP bought a new position in shares of Humana Inc. (NYSE:HUM) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 5,618 shares of the insurance provider’s stock, valued at approximately $1,352,000.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. Northwestern Mutual Wealth Management Co. boosted its position in shares of Humana by 139.5% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after purchasing an additional 325 shares in the last quarter. Capital Fund Management S.A. purchased a new stake in shares of Humana during the 2nd quarter worth $73,091,000. Martingale Asset Management L P purchased a new stake in shares of Humana during the 2nd quarter worth $482,000. Alliancebernstein L.P. boosted its position in shares of Humana by 109.7% during the 2nd quarter. Alliancebernstein L.P. now owns 527,709 shares of the insurance provider’s stock worth $126,977,000 after purchasing an additional 276,043 shares in the last quarter. Finally, Aberdeen Asset Management PLC UK boosted its position in shares of Humana by 87.5% during the 2nd quarter. Aberdeen Asset Management PLC UK now owns 159,210 shares of the insurance provider’s stock worth $38,309,000 after purchasing an additional 74,305 shares in the last quarter. Institutional investors own 95.12% of the company’s stock.
HUM has been the topic of several research analyst reports. UBS AG restated a “neutral” rating and set a $250.00 target price (up from $237.00) on shares of Humana in a research report on Wednesday, August 9th. Zacks Investment Research lowered shares of Humana from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Cowen and Company restated a “buy” rating and set a $230.00 target price on shares of Humana in a research report on Friday, July 14th. BidaskClub upgraded shares of Humana from a “sell” rating to a “hold” rating in a research report on Thursday, August 10th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $223.00 target price (up from $200.00) on shares of Humana in a research report on Thursday, August 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company’s stock. Humana currently has an average rating of “Buy” and an average target price of $244.35.
COPYRIGHT VIOLATION WARNING: “Ajo LP Invests $1.35 Million in Humana Inc. (HUM)” was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://stocknewstimes.com/2017/09/20/ajo-lp-invests-1-35-million-in-humana-inc-hum.html.
In other news, CEO Bruce D. Broussard sold 12,000 shares of the company’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the completion of the sale, the chief executive officer now directly owns 80,086 shares of the company’s stock, valued at $20,172,061.68. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Brian P. Leclaire sold 4,971 shares of the company’s stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total value of $1,193,040.00. Following the sale, the senior vice president now directly owns 14,258 shares of the company’s stock, valued at $3,421,920. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 60,566 shares of company stock valued at $15,326,746. 0.80% of the stock is currently owned by company insiders.
Humana Inc. (NYSE HUM) opened at 240.04 on Wednesday. Humana Inc. has a 52 week low of $163.50 and a 52 week high of $259.76. The firm has a market cap of $34.69 billion, a P/E ratio of 19.75 and a beta of 0.87. The company has a 50-day moving average of $250.95 and a 200 day moving average of $232.23.
Humana (NYSE:HUM) last announced its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, beating the consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The business had revenue of $13.53 billion during the quarter, compared to the consensus estimate of $13.61 billion. During the same period in the prior year, the business posted $2.30 earnings per share. On average, equities analysts predict that Humana Inc. will post $11.55 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.67%. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio is 13.06%.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.